Investors - Linden Lake Labs

Invest Where Breakthroughs Begin

Early science holds extraordinary potential. At Linden Lake Labs, we help realize that potential by building and backing companies at the critical first stages, where insight, structure, and timing matter most.

A Platform for Early-Stage Value Creation

Linden Lake Labs is a life sciences platform focused on developing and investing in preclinical therapeutics with the potential to reshape human health. We work side by side with founders, scientists, and investors to turn emerging science into fully operational companies—supporting them with strategic capital, centralized operations, and long-range planning from day one.

Our model is designed to move assets forward with discipline and efficiency, guiding companies toward M&A, licensing, or IPO based on optimal value and timing.

We do not wait for opportunity to arrive. We build it.

Therapeutic Focus Areas

We prioritize therapeutic areas where need is high and science can make the greatest difference. These areas are where our platform, infrastructure, and expertise can accelerate development and reduce time to value.

Oncology

Including antibody-drug conjugates (ADCs), immune modulators, and novel biologics

Central Nervous System (CNS) Disorders

Targeting neurodegenerative and neurological diseases

Rare and Orphan Conditions

Focused on high-need, underserved populations with targeted interventions

Why Invest in
Linden Lake Labs

Proven Execution

Our leadership team brings decades of experience in life sciences, intellectual property, and strategic finance. They’ve consistently created value by launching and scaling early-stage ventures with strong science and disciplined planning.

Capital-Efficient Model

By centralizing IP, legal, finance, and regulatory functions, we reduce friction and maximize the value of every dollar invested. Our platform lowers the cost of innovation while maintaining strategic flexibility.

Embedded Infrastructure

Our ventures benefit from direct access to lab space, manufacturing capabilities, and quality systems from day one. This allows for faster validation, greater independence, and lower overhead during critical development phases.

Global Innovation Engine

We source and evaluate breakthrough science from academic institutions in the U.S., Europe, and India—giving us early access to diverse, world-class IP and talent.

Multiple Exit Pathways

We design each company with optionality in mind—targeting outcomes through licensing, M&A, or public market strategies, based on asset maturity and market dynamics.

Aligned Incentives

Investing in Linden Lake Labs means participating in the momentum of the full platform. Our structure allows investors to benefit from a diversified group of ventures, each positioned for real-world impact and long-term return.

Companies We’ve Built and Backed

We invest in and create early-stage biotech companies with strong scientific foundations and clear paths to value. Our portfolio includes ventures launched through our internal studio as well as strategic investments in seed and pre-Series A-stage startups. Each reflects our focus on high-impact science, disciplined execution, and long-term potential.

Xcellon Biologics

Xcellon is a Maryland-based CDMO specializing in complex biologics, including ADCs, bispecific antibodies, and T-cell engagers.

Degenova

This is placeholder text until we get more specific information about Degenova.

Stage One Therapeutics

This is placeholder text until we get more specific information about Stage One Therapeutics.

Falcon BioPharma

This is placeholder text until we get more specific information about Falcon BioPharma.

Invest in what comes next

If you are seeking early access to vetted biotech opportunities backed by scientific, legal, and operational expertise, we would welcome the opportunity to connect.

Linden Lake Labs is actively raising capital to support future investments and is open to discussions with accredited investors and strategic partners.